Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 65,000 shares at $0.16 ($11K) on 2022-10-19, disclosed to the SEC on 2022-10-24.
Seasonal purchase ($11k) by Chairman and CEO, 10% Owner — this insider has traded EMMA in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.16 | 25,000 | $4K | 35.4% |
| 2 | $0.18 | 30,000 | $5K | 47.8% |
| 3 | $0.19 | 10,000 | $2K | 16.8% |
| Total | $0.17 avg | 65,000 | $11K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |
| EMMA | BUY | 2022-10-17 | $17K | — | Filing → |